Application 103132
- Type
- BLA
- Sponsor
- SCHERING
Purple Book Biologic Products#
BLA, Proprietary name, Proper name table| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|
| 103132 | Intron A | interferon alfa-2b | 351(a) | Disc | 2026-06-01 |
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | INTRON A | INTERFERON ALFA-2B | VIAL | 10MIU/VIAL | No | No |
| 002 | INTRON A | INTERFERON ALFA-2B | VIAL | 18MIU/VIAL | No | No |
| 003 | INTRON A | INTERFERON ALFA-2B | VIAL | 25MIU/VIAL | No | No |
NDC Listings For This Application#
NDC listings for this application page 1 of 1 ยท 25 matching rows.
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 0085-1133 | INTRON A | Interferon alfa-2b | Merck Sharp & Dohme Corp. | BLA | Current |
| 0085-1133 | INTRON A | Interferon alfa-2b | Merck Sharp & Dohme LLC | BLA | Current |
| 0085-1133 | INTRON A | Interferon alfa-2b | Merck Sharp & Dohme Corp. | BLA | Current |
| 0085-1133 | INTRON A | Interferon alfa-2b | Merck Sharp & Dohme Corp. | BLA | Current |
| 0085-1133 | INTRON A | Interferon alfa-2b | Merck Sharp & Dohme Corp. | BLA | Current |
| 0085-1168 | INTRON A | Interferon alfa-2b | Merck Sharp & Dohme Corp. | BLA | Current |
| 0085-1168 | INTRON A | Interferon alfa-2b | Merck Sharp & Dohme LLC | BLA | Current |
| 0085-1168 | INTRON A | Interferon alfa-2b | Merck Sharp & Dohme Corp. | BLA | Current |
| 0085-1168 | INTRON A | Interferon alfa-2b | Merck Sharp & Dohme Corp. | BLA | Current |
| 0085-1168 | INTRON A | Interferon alfa-2b | Merck Sharp & Dohme Corp. | BLA | Current |
| 0085-4350 | INTRON A | interferon alfa-2b | Merck Sharp & Dohme Corp. | BLA | Current |
| 0085-4350 | INTRON A | interferon alfa-2b | Merck Sharp & Dohme LLC | BLA | Current |
| 0085-4350 | INTRON A | interferon alfa-2b | Merck Sharp & Dohme Corp. | BLA | Current |
| 0085-4350 | INTRON A | interferon alfa-2b | Merck Sharp & Dohme Corp. | BLA | Current |
| 0085-4350 | INTRON A | interferon alfa-2b | Merck Sharp & Dohme Corp. | BLA | Current |
| 0085-4351 | INTRON A | interferon alfa-2b | Merck Sharp & Dohme Corp. | BLA | Current |
| 0085-4351 | INTRON A | interferon alfa-2b | Merck Sharp & Dohme LLC | BLA | Current |
| 0085-4351 | INTRON A | interferon alfa-2b | Merck Sharp & Dohme Corp. | BLA | Current |
| 0085-4351 | INTRON A | interferon alfa-2b | Merck Sharp & Dohme Corp. | BLA | Current |
| 0085-4351 | INTRON A | interferon alfa-2b | Merck Sharp & Dohme Corp. | BLA | Current |
| 0085-4352 | INTRON A | interferon alfa-2b | Merck Sharp & Dohme Corp. | BLA | Current |
| 0085-4352 | INTRON A | interferon alfa-2b | Merck Sharp & Dohme LLC | BLA | Current |
| 0085-4352 | INTRON A | interferon alfa-2b | Merck Sharp & Dohme Corp. | BLA | Current |
| 0085-4352 | INTRON A | interferon alfa-2b | Merck Sharp & Dohme Corp. | BLA | Current |
| 0085-4352 | INTRON A | interferon alfa-2b | Merck Sharp & Dohme Corp. | BLA | Current |